OUR PIPELINE

" We aim above the mark to hit the mark." — Ralph Waldo Emerson

介绍详情

Pipeline

Delivering advances in both Oncology and Immunology

 

Tavotek is developing a portfolio of drug candidates to treat inflammatory diseases and difficult to treat cancers.  Our scientists are working relentlessly to discover and develop transformational medicines for patients worldwide.



Immunology

  • Discovery
  • Lead Optimization
  • Preclinical
  • IND-Enabling
  • Phase 1
  • Phase 2
  • Tavo 101

  • Tavo 103A

Oncology

  • Discovery
  • Lead Optimization
  • Preclinical
  • IND-Enabling
  • Phase 1
  • Phase 2
  • Tavo 412

  • Tavo 421

  • Tavo 501

Tavo ELITE

  • Discovery
  • Lead Optimization
  • Preclinical
  • IND-Enabling
  • Phase 1
  • Phase 2
  • Undisclosed

  • Undisclosed

  • Undisclosed

727 Norristown Road, 3 Spring House Innovation Park Suite 101, Lower Gwynedd, Pennsylvania 19002

China. Suzhou. Suzhou Industrial Park. Unit 405, Building C2, No. 218, Xinghu Street

© 2022 Tavotek Biotherapeutics All rights reserved.   (267) 405-9426

© 2022 Tavotek Biotherapeutics All rights reserved.(267) 405-9426